Urology

Our focus

Transforming lives with comprehensive solutions to support kidney stone removal, prostate health, erectile restoration and urinary continence.

Amy’s story

Delivering meaningful innovation

Advancing kidney stone management.

Boston Scientific conducted research around the world to study how flexible ureteroscopy and percutaneous nephrolithotomy procedures are being conducted and how they can be improved. This research indicated that retrieving kidney stones is one of the most time-consuming steps during ureteroscopy procedures. The insights gathered and the solutions that come from them resulted in StoneSmart™ Solutions — our vision to transform urologic stone care and address some of the biggest challenges urology providers face today.*

Expanding options for addressing prostate health.

Boston Scientific has a growing portfolio of products that may impact the quality of life and clinical outcomes for people undergoing radiotherapy for prostate cancer and benign prostatic hyperplasia (BPH).

In one study evaluating Rezūm™ Water Vapor Therapy, patients experienced significant improvements of BPH symptoms sustained through 5 years of follow-up.¹

SpaceOAR™ Hydrogel is used by physicians at 10 of the top 10 U.S. cancer centers in 2023.²

Designed for satisfaction as a long-term treatment option for erectile dysfunction, more than 500K AMS 700™ Inflatable Penile Prostheses have been sold worldwide.²

Some conditions our customers manage:

Kidney Stones
Benign Prostatic Hyperplasia (BPH)
Prostate Cancer Radiotherapy Side Effects
Erectile Dysfunction
Pelvic Floor Disorders (Stress Urinary Incontinence and Pelvic Organ Prolapse)
Male Incontinence

12%

of the population worldwide affected by kidney stone disease.³

50%

of U.S. men affected by benign prostatic hyperplasia by age 60.⁴

~ 1

in 5 U.S. men, aged 20 and older, suffers from some degree of erectile dysfunction (ED).⁵

in every 2 U.S. women, experience involuntary leakage of urine.⁶

Focus areas

Stone Management Solutions
BPH Treatment Options
Hydrogel Perirectal Spacer Placed Prior to Prostate Cancer Radiation Therapy
Penile Implants for Erectile Dysfunction
Urinary Control Systems for Male Stress Urinary Incontinence
Mid-Urethral Slings and Urethral Bulking Agent for Female Stress Urinary Incontinence

Product spotlights

Lumenis Pulse™ 120H Holmium Laser System with MOSES™ 2.0 Technology

Lumenis Pulse™ 120H Holmium Laser System with MOSES™ 2.0 Technology can help reduce operative times for lithotripsy and benign prostatic hyperplasia (BPH) treatments compared to standard holmium.⁷, ⁸, ⁹

Learn more about the Lumenis Pulse

LithoVue™ Elite Single-Use Digital Flexible Ureteroscope

The LithoVue™ Elite Single-Use Digital Flexible Ureteroscope is the only ureteroscope with intrarenal pressure (IRP) monitoring designed to allow users to make informed, real-time clinical decisions in kidney stone management.

Learn more about the LithoVue Elite

AMS 700™ Inflatable Penile Prosthesis

AMS 700™ Inflatable Penile Prosthesis is designed to provide long-term treatment for patients with erectile dysfunction. A category leading, physician-preferred prosthesis* designed for ease of use and to look and feel natural.

Learn more about the AMS 700 Series

SpaceOAR® Hydrogel Spacers

SpaceOAR hydrogel is an absorbable hydrogel that temporarily creates space between the prostate and rectum, designed to help reduce the radiation dose delivered to the rectum during prostate cancer radiation therapy. SpaceOAR has been demonstrated to help reduce the common side effects of prostate cancer radiotherapy such as late rectal toxicity, urinary incontinence and urinary toxicity.¹⁰ SpaceOAR Vue is the next generation hydrogel spacer that offers visibility via CT Scan, designed to help physicians improve contouring accuracy and consistently position patients receiving prostate cancer radiation.

Learn more about the SpaceOar Hydrogel Spacers

Rezūm™ Water Vapor Therapy

Rezūm™ Water Vapor Therapy is a minimally invasive treatment intended to alleviate the cause of BPH – an enlarged prostate. This therapy delivers sterile steam directly to the targeted tissue. Clinical studies demonstrated that over time the steam reduces the volume of the prostate to relieve BPH symptoms, while preserving sexual function.¹, ¹¹

Learn more about the Rezūm System

Sources

McVary KT, Gittelman MC, Goldberg KA. Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urology. 2021 Sep;206(3):715-724.
Based on Boston Scientific sales data for SpaceOAR^TM Hydrogel and SpaceOAR Vue^TM Hydrogel (to institutions in 2022 and 2023) and AMS 700^TM (as of May 2024).
Alelign T, Petros B. Kidney stone disease: An update on current concepts. Adv Urol. 2018 Feb 4;3068365.
Barry M, Roehrborn C. Management of benign prostatic hyperplasia. Annu Rev Med. 1997 Feb;48:177-89.
Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120:151–157.
Patel UJ, Godecker AL, Giles DL, Brown HW. Updated prevalence of urinary incontinence in women: 2015–2018 national population-based survey data. Female Pelvic Med Reconstr Surg. 2022;28:181–187.
Ibrahim A, Elhilali MM, Fahmy N, et al. Double-blinded prospective randomized clinical trial comparing regular and Moses modes of holmium laser lithotripsy. J Endourol. 2020 May;34(5):624-8.
Whiles BB, Martin AJ, Brevik A, et al. Utilization of Moses modulated pulse mode results in improved efficiency in holmium: YAG laser ablation of the prostate. Urology. 2021 Mar;149:18792.
Kavoussi NL, Nimmagadda N, Robles J, et al. MOSES technology for holmium laser enucleation of the prostate: A prospective double‐blind randomized control trial. J Urol. 2021 Jul;206(1):104-8.
Armstrong N, et al. SpaceOAR Hydrogel Spacer for Reducing Radiation Toxicity During Radiotherapy for Prostate Cancer. A Systematic Review. Urology. 2021 Oct;156:e74-e85. doi: 10.1016/j.urology.2021.05.013. Epub 2021 May 23. PMID: 34029607.
Mynderse L A, Hanson D, Robb R et al. Rezūm system water vapor treatment for lower urinary tract symptoms/benign prostatic hyperplasia: validation of convective thermal energy transfer and characterization with magnetic resonance imaging and 3-dimensional renderings. J Urology. 2015 Jul;86(1):122-7.

*Market research study sponsored by Boston Scientific. Data on file.

Boston Scientific acquired the global surgical business of Lumenis Ltd. Lumenis Pulse™ 120H is the registered product name. Lumenis Pulse™ 120H with MOSES Technology is manufactured and sold by Boston Scientific. Lumenis is a registered trademark of Lumenis Be.

Rx Only

CAUTION: U.S. Federal law restricts this device to sale by or on the order of a physician.

All images are the property of Boston Scientific. All trademarks are the property of their respective owners.